Catena Biosciences

Developer of an advanced protein coupling technology intended to cure autoimmune disorders. The company’s technology allows the attachment of any two proteins together faster and more selectively than any competing method by attaching the natural amino acids tyrosine and cysteine, helping clients in the creation of novel therapeutics in autoimmune disorders, oncology, and vaccine development.